Xcout IntelSign inSubscribe

Fulgent Genetics, Inc.

FLGTHealthtechEl Monte, CA, United States

Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular profiling for cancer identification, Beacon carrier screening for inherited conditions, and specialized rapid whole genome testing for critically ill infants in NICU and PICU units. Other offerings include a newborn genetic analysis panel, a front-line test to sequence ataxia-related variants, and patient-initiated genetic testing via Picture Genetics. They also provide comprehensive whole exome, clinical exome, whole genome, mutation, and repeat expansion testing, alongside research service tests. For COVID-19, the company delivers next-generation sequencing, reverse transcription polymerase chain reaction (RT-PCR), and antigen-based diagnostic solutions for SARS-CoV-2. Beyond genetic and COVID-19 diagnostics, Fulgent Genetics performs advanced laboratory analyses such as flow cytometry for cell analysis and malignancy monitoring, fluorescence in-situ hybridization (FISH) for specific DNA sequence detection, immunohistochemistry (IHC) to visualize cellular antigens, and cytogenetics for assessing chromosomal anomalies, in addition to molecular testing for both hematopoietic and solid tumors. Their clientele is broad, including insurance companies, hospitals, medical institutions, fellow laboratories, government agencies, payors, municipal bodies, major corporations, and direct patients. The company has formed a strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. Founded in 2011 and headquartered in Temple City, California, the company was previously known as Fulgent Diagnostics, Inc. before adopting its current name in August 2016.

Subscribe to see Fulgent Genetics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Fulgent Genetics, Inc. at a glance

Fulgent Genetics, Inc. is a healthtech company headquartered in El Monte, United States. It is publicly listed (FLGT) with a market capitalisation of $718M. Xcout tracks 14 named people at Fulgent Genetics, Inc., including Ming Hsieh (Chairman & Chief Executive Officer).

As of 16 November 2026. Source: Xcout Intel.

Industry
Healthtech
Headquarters
El Monte, CA, United States
Market cap
$718M
Employees
1,313
Ticker
FLGT
Web attention
Top 1M website · steady over 3 months

Fulgent Genetics, Inc. leadership

  • Ming HsiehChairman & Chief Executive Officer
  • Jian XieChief Operating Officer & President
  • Paul KimChief Financial Officer
  • Hanlin Gao FACMGChief Scientific Officer & Laboratory Director
  • Brandon PerthuisChief Commercial Officer
  • Elias NyankojoChief Information Security Officer

8 more named people on record for Fulgent Genetics, Inc., with roles, board committees and tenure — see the full roster →

Who owns Fulgent Genetics, Inc.

142 institutions reported a position for the quarter ending 30 June 2026, and 6 insiders hold at least 0.1% of the shares.

BlackRock: 8.30%Vanguard: 4.00%Ming Hsieh: 4.00%Acadian Asset Management: 3.70%Hanlin Gao: 3.60%Other institutions: 41.00%Other insiders: 2.90%Not held by 13F institutions or listed insiders: 32.50%Fulgent Genetics,…57.0%held byinstitutions
Ownership of Fulgent Genetics, Inc. by 13F institution and insider
Holder% of shares outstanding
BlackRock8.30%
Vanguard4.00%
Ming Hsieh4.00%
Acadian Asset Management3.70%
Hanlin Gao3.60%
Other institutions41.00%
Other insiders2.90%
Not held by 13F institutions or listed insiders32.50%
  1. 1BlackRockBlackRock, Inc.8.3%
  2. 2Vanguard4 filers: VANGUARD CAPITAL MANAGEMENT LLC · VANGUARD PORTFOLIO MANAGEMENT LLC · VANGUARD FIDUCIARY TRUST CO · Vanguard Global Advisers, LLC4.0%
  3. 3Ming HsiehIndividualChief Executive Officer, director, 10% ownerFiled as Hsieh Ming · 3 Sep 20264.0%
  4. 4Acadian Asset ManagementACADIAN ASSET MANAGEMENT LLC3.7%
  5. 5Hanlin GaoIndividualChief Scientific OfficerFiled as Gao Hanlin · 3 Sep 20263.6%

The full list of 142 institutions, with share counts and what each bought or sold since the previous quarter.

Sign in to see it, or subscribe →

Source: SEC Form 13F filings, period ending 30 June 2026; shares outstanding from the company's 10-Q as of 27 July 2026. 13F covers the US-listed holdings of investment managers with more than $100 million under management and is filed up to 45 days after the quarter ends. A firm that files under several names (Vanguard files as two managers) is one row, with its filers listed under it. Individuals are company insiders (directors, officers and 10% owners) holding at least 0.1% of the shares, from their latest SEC Form 3, 4 or 5 (newest 3 September 2026), counting shares held directly and through trusts and other entities they report, including high-vote class shares (such as Class B); options and restricted stock units are not counted. They are a separate slice from the 13F institutions, so the ring adds up to 100%: what is left is held by smaller insiders, retail investors and anyone else who does not file.

Fulgent Genetics, Inc. competitors

A few of Fulgent Genetics, Inc.'s closest competitors — see the full list of competitors and alternatives →

Get Fulgent Genetics, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Fulgent Genetics, Inc.? Suggest a correction · Work at Fulgent Genetics, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Fulgent Genetics, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Fulgent Genetics, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Fulgent Genetics, Inc. in Xcout Intel

  • 14 named people with titles, LinkedIn and board committees
  • 3 corporate events with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →